C-Rad AB (OM:CRAD B) commences an Equity Buyback Plan, under the authorization approved on May 5, 2023.
August 21, 2023 at 06:30 am EDT
Share
Boozt AB (publ) (OM:BOOZT) commences share repurchases on August 15, 2023, under the program mandated by the shareholders in the Annual General Meeting held on May 5, 2023. As per the mandate, the company is authorized to repurchase its Class B shares. The repurchases will be made such that the own shareholding of the company does not exceed 10% of all shares in the company. The price to be paid for repurchase is the price interval between highest purchase price and the lowest sale price. The purpose of the program is to be able to adapt the group's capital structure and to enable future acquisitions of companies or operations to take place through payment with own shares. The authorization will be valid till Next Annual General Meeting of the company.
On July 19, 2023, the company announced a share repurchase program. Under the program, the company will repurchase up to 88,500 shares. The program will commence on June 22, 2023, and will be valid till next Annual General Meeting in 2024. As of July 19, 2023, the company had 862,887 class A shares and 32,904,048 class B shares.
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Companyâs largest shareholder is Inter Life Science AB.